As of the end of August, the comprehensive net asset value per share of CAPITAL VC (02324) was approximately HK$0.9025.

Pharmaron Beijing's subsidiary, Kanglong Shaoxing, passed the on-site inspection by the US FDA.

Mengniu Dairy (02319) spent approximately HK$3.0636 million on repurchasing 200,000 shares on September 15th.

Shenzhen Kangtai Biological Products (300601.SZ): Sabin strain inactivated poliomyelitis vaccine (Vero cells) has obtained a drug registration certificate.